Search
-
Public Opinion on the COVID-19 pandemic
In an uncertain world, data matters. Ipsos experts share the latest research and analysis related to the coronavirus pandemic.
-
MADE IN RUSSIA: Pride in the Russian Automotive Industry
The Ipsos team in Russia decided to ask the Russian consumers if they now perceive Russia to be a manufacturer of high-tech industrial goods. To what extent are people ready to be proud of domestic technologies? How sought-after and useful will the use of this issue be in the communication of Russian and international brands?
-
DO GOOD: Why Russians Engage in Charity
This paper explains what drives private charity givers, and what businesses should take into account to make their charitable campaigns successful.
-
Pride in the Russian automotive industry
The Ipsos team in Russia decided to ask the Russian consumers if they now perceive Russia to be a manufacturer of high-tech industrial goods. To what extent are people ready to be proud of domestic technologies? How sought-after and useful will the use of this issue be in the communication of Russian and international brands?
-
Insight Out: an Ipsos UU podcast
Insight Out is a monthly podcast exploring emerging trends, budding innovations and creative ways to get closer to real people in real life.
-
Decoding the patient journey with social insights
Social insights have become a critical component of understanding patients, HCPs, and caregivers – and a key input into developing products and services that meet their needs.
-
Social capital
Social capital is made up of a web of social relations that allow us to thrive – or cause us to struggle when absent. Social capital is what generates social cohesion and connectedness, and it is created through reciprocity, trust, and cooperation between and amongst individuals who make up a social unit. Access to social capital is a determinant of well-being in society.
-
How has the Covid crisis impacted the image of pharmaceutical companies in France?
2021 put the spotlight firmly on pharmaceutical companies, whose image has been enhanced by the leading role they have played in combating the pandemic. Confidence indicators in the industry itself, as well as in pharmaceutical products and vaccines in general, are on the rise, but cannot conceal structural image issues for the sector as a whole, as is the case with combating shortages or the pursuit of the public interest.